Fear is in the air. Sure, the S&P 500 (^GSPC +2.91%) is holding up pretty well in the face of significant uncertainty. However, implied volatility has risen sharply in recent weeks.Should investors stay away from all stocks with a 10-foot pole? Nope. Here are three dividend stocks you can buy with no hesitation. 1. Johnson & JohnsonJohnson & Johnson (JNJ +0.83%) remains a favorite among investors who want to sleep at night without worrying about their portfolios. The healthcare giant has an AAA credit ratin ...

Investment Thesis I value Johnson & Johnson (NYSE:JNJ) with a Hold judgment. The company is well-appreciated by investors for being one of the biggest and most diversified players in the pharmaceutical industry, a defensive stock with a long history (62 years) of dividend increase. Given the considerable capital increase the company has been realizing in the last year, this analysis aims to quantitatively evaluate if the company is still undervalued, fairly valued, or overvalued. The outcome of the Monte Ca ...

Equity markets have experienced significant volatility this year, and given broader macroeconomic conditions, including rising oil prices, trade wars, and actual wars, things might not fully settle down anytime soon. In this environment, it's a great idea to invest in dividend stocks. Not only do consistent dividend payers tend to have robust businesses capable of navigating challenging economic times, but their regular payouts can also help smooth out market losses. However, not all dividend companies ar ...

Johnson & Johnson Stock Is Finally Rebounding | Investor's Business Daily TRENDING: Investors Rethink How To Safeguard Assets In Trump's Iran War Johnson & Johnson Johnson & Johnson JNJ $ 243.60 $1.11 0.46% 32% IBD Stock Analysis IBD Composite Rating 91/99 Industry Group Ranking 91/197 Emerging Pattern Flat Base Flat Base One of three positive chart patterns to look for when doing technical analysis. It usually occurs after a stock has advanced off of a "cup with handle†or "double bottom†pattern. The ...

Ariel Investments, an investment management company, released its "Ariel Focus Fund" fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Ariel Focus Fund delivered mixed results in the fourth quarter of 2025, declining -0.50% and underperforming both the S&P 500 and Russell 1000 Value indices, which gained +2.66% and +3.81%, respectively, although the fund outperformed both benchmarks over the full year with a +20.97% return. The quarter took place in a resilient U.S. market en ...

Johnson & Johnson (NYSE:JNJ) was among the stocks Jim Cramer highlighted, along with his latest game plan as the oil-shock-driven sell-off continues. Cramer mentioned the stock during the episode and said: Now, what I suggest you do is look at Johnson & Johnson. Until it became clear that the impact wouldn’t be as bad, the stock was in free fall, and then when it was clear, it went from $140 to $230 almost in the blink of an eye. I think the same thing will happen here. Stock market data. Photo by Bura ...

Quick Read Johnson & Johnson (JNJ) raised its quarterly dividend from $1.24 to $1.30 per share (5% increase) and extended its consecutive dividend hike streak to 63 years, yielding 2.14% annually with a sustainable 46.7% payout ratio and $19.7 billion in free cash flow. Pfizer (PFE) carries payout ratio risk at 118.6% despite higher yield, while Merck (MRK) lacks Johnson & Johnson’s breadth and reliability track record. Johnson & Johnson’s diversified portfolio of medicines, medical devices, and consume ...

Here's Why You Don't Bet Against This Dividend King - 24/7 Wall St. S&P 5006,437.70 +1.39% Dow Jones45,713.20 +0.99% Nasdaq 10023,324.80 +1.61% Russell 20002,453.53 +1.64% FTSE 10010,172.40 +0.90% Nikkei 22551,667.30 +1.25% Stock Market Live March 31, 2026: S&P 500 (SPY) Pops on News Trump Could End War Investing Here's Why You Don't Bet Against This Dividend King By Rich DupreyPublished Mar 31, 11:30AM EDT Quick Read Johnson & Johnson (JNJ) raised its quarterly dividend from $1.24 to $1.30 per share (5% ...

Market Sentiment - The CNN Fear & Greed Index is at 13, indicating Extreme Fear, a significant drop from 8, the lowest level since 2022, when the collapse of Terraform Labs led to a $440 billion loss in market capitalization within a week [2][5] - The S&P 500 has declined by 7% year-to-date, while the Nasdaq-100 has entered correction territory due to its higher tech exposure [3] Investment Opportunities - Despite the overall market panic, high-quality companies like Apple, Microsoft, and Johnson & Johnson are trading at attractive valuations, with Apple reporting a revenue of $143.8 billion, a 16% year-over-year increase, and a diluted EPS of $2.84, up 19% [6][7] - Microsoft has a forward P/E ratio of 22.26x, while Johnson & Johnson offers a yield of 2.14%, indicating potential value for investors looking to deploy capital in quality names during this period of extreme fear [7] Market Behavior - The current sell-off has affected even the strongest companies with solid balance sheets and growing cash flows, surprising many retail investors [6] - The extreme fear level has only been observed on about 3.4% of trading days since 2011, suggesting a historically opportune moment for investors to consider quality investments rather than panic-selling [5][7]

Extreme Fear is Gripping the Market, This Is the Smart Move Most Investors Miss - 24/7 Wall St. Quick Read S&P 5006,416.40 +1.06% Dow Jones45,734.20 +1.04% Nasdaq 10023,210.80 +1.11% Russell 20002,446.83 +1.36% FTSE 10010,222.70 +1.40% Nikkei 22551,627.30 +1.18% Investing Extreme Fear is Gripping the Market, This Is the Smart Move Most Investors Miss By Rich DupreyPublished Mar 31, 8:09AM EDT Apple (AAPL), Microsoft (MSFT), and Johnson & Johnson (JNJ) are trading at attractive valuations despite posting ...